A new study led by Columbia University researchers projects a substantial rise in uterine cancer incidence and deaths in the ...

Polycystic Ovary Syndrome is rising among Indian women, especially in urban areas. This article explores its symptoms, ...

Key risk factors include delayed childbearing and declining fertility rates, limited access to regular gynecological care and ...

On the basis of differences in histology and clinical outcomes, endometrial cancers have long been divided into two types. 1–4 Type I tumors comprise the large majority of endometrial cancers, are ...

The NHS has agreed a pair of commercial deals with Merck & Co/MSD and Eisai that will allow hundreds of women with advanced endometrial cancer to get access to life-extending combination therapy ...

GSK and Merck & Co have both reported new clinical data with the PD-1 checkpoint inhibitors, seeking an edge in the first-line treatment of advanced endometrial cancer. Results of GSK’s RUBY ...

Recently, data on recurrence and survival, quality of life and sexual function from the LAP2 cohort have become available. [] In 2012, with a median follow-up time of 59 months for 2181 patients ...